In a recent development, Infinite Brain Technologies (IBT) and ATLATL Innovation Centre (ATLATL) have formally entered into a Memorandum of Understanding. These two renowned organizations, distinguished in their respective fields, have united with the common objective of advancing the realm of brain health technology seamlessly integrated with artificial intelligence (AI).

IBT Global, originating from China, has emerged as a prominent player in the Digital Therapeutics (DTx) landscape. With a seasoned cross-functional team operating at the intersection of neuroscience and software technology, IBT Global specializes in developing patient-facing software applications that have demonstrated clinical efficacy, ultimately leading to improved outcomes for patients.

On the other hand, the ATLATL Center for Innovation & Research stands as a global hub for innovation research and development. Situated at the epicenter of various prestigious science parks, it is fostering a vibrant life sciences ecosystem by collaborating with entrepreneurs, investors, pharmaceutical firms, and service providers.

Dr. Wei Sun, the Founder and Chairman of IBT, expressed his enthusiasm for the collaboration: "IBT's dedicated team is committed to the global development of precise Digital Therapeutics for brain health. We are both pleased and honored to partner with ATLATL to pioneer the advancement of accurate digital therapeutics for brain health by harnessing advanced AI technologies."

ATLATL's CEO, PC Zhu, shared his vision for ATLATL's role in the global brain health industry: "ATLATL is renowned for its state-of-the-art infrastructure, efficient operational management, specialized core facilities, and collaborative on-site research services. IBT has garnered recognition for its expertise in crafting precise digital therapeutics through cutting-edge AI technologies. We consider it a privilege to collaborate with IBT in elevating global innovation within the realm of brain health."

Justin Jia, IBT's Chief Technology Officer and CEO of IBT Global, expressed his excitement about the partnership: "We are truly thrilled to join forces with ATLATL, capitalizing on their extensive R&D capabilities and extensive bio-tech networks. IBT is steadfast in its mission to pioneer cutting-edge AI-powered digital therapeutics, with the ultimate aim of delivering effective clinical solutions to individuals facing the challenges of mental disorders."

 

Source: businesswire.com

Report Abuse